Artificial intelligence improves accuracy of body surface area estimation in drug dosing, suggesting better clinical applications.
Total body surface area (BSA) is thought to be a better predictor of metabolic mass than body weight because it is less affected by abnormal adipose mass, and as a result, it is often used for drug dosing in clinical medicine. There are several formulae used for estimating BSA, however, most are based on 2-dimensional and not 3-dimensional BSA measurements or used naïve statistical techniques to create the estimating formulae. This study analyzed 3-dimensional whole-body positron emission tomography/computed tomography studies from 698 patients. A limitation of this dataset was the imbalance in racial distribution. BSA was obtained from the computed tomography component of these studies using TotalSegmentator software. There was a positive correlation between BSA and height ( R = 0.49, P < .001), and between BSA and weight ( R = 0.83, P < .001). Multivariable ridge regression with 5-fold cross-validation was used to create new formulae to estimate BSA by adjusting for sex, race, height, and weight. The optimal formula to estimate BSA in m 2 , is , where H is height in meters and W is weight in kilograms. Our formulae were significantly more accurate than all other formulae and had a lower mean absolute error and mean squared error than the Dubois ( P < .001, P < .001), Mosteller ( P < .001, P < .001), Haycock ( P < .001, P < .001), Gehan ( P < .001, P < .001), Boyd ( P < .001, P < .001), Fujimoto ( P < .001, P < .001), Takahira ( P < .001, P < .001), Shuter and Aslani ( P < .001, P < .001), Lipscombe ( P < .001, P < .001), and Schlich ( P < .001, P < .001) BSA formulae respectively.
No takes yet. Share an insight, caveat, or question.
Sebro et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: